TOP

Products
Products

At Gen Re, we believe that information and collaboration are the basis for great innovation.

We leverage the actuarial, medical, and underwriting expertise of our global units with the market-specific knowledge of our regional departments to support your product initiatives.

Our product development support comprises a wide range of services needed by primary insurers, including design of new products, calculation of the respective rates, and development of policy terms and conditions. Post-launch, our portfolio monitoring and experience studies offer additional valuable insights.

Our Products

Card Image

Mortality

Card Image

Longevity

Card Image

Disability

Card Image

Critical Illness/
Dread Disease

Card Image

Health

Card Image

Long Term Care

Our Services

Underwriting

Risk assessment of individual lives is a core strength at Gen Re. We offer services in all areas of risk assessment.

Learn More

Market Research & Surveys

Understand biometric risks – from single portfolios to market-wide surveys.

Learn More

Analytics

Using a wide range of techniques such as random forest, GLMs or neural networks our data scientists get the most of complex data; always in collaborations with our experts from other fields a maximum of insights and interpretability is achieved.

Learn More

Digital Solutions

We help our clients create digital solutions across the insurance value chain.

Learn More

Recent Research

Understanding Breast Cancer in Asia – Awareness and the Importance of Screening
Breast cancer ranks as the most prevalent cancer worldwide, and a staggering 2.3 million women were diagnosed with the illness globally in 2020. Although the prospects of survival in the battle against breast cancer are improving, the financial burden on patients remains significant. CI benefits can assist with managing the expenses.
Wendy Low, Pei Nee Yong, Samuel Lim
All in a Day’s Work – The Impact of Non-Medical Factors in Disability Claims
Understanding both the medical and non-medical factors impacting a claim remains key to risk management and is necessary for both stay-at-work and return-to-work planning. Here we explore the non-medical determinants of health and options beyond medical management to assist with return-to-work planning and success.
Mary Enslin, Lisa Hall
Join the Fight Against Cervical Cancer
Cervical cancer is mainly caused by human papillomavirus (HPV) infection. Thanks to the development of prophylactic HPV vaccination, it is possible to eliminate cervical cancer. We discuss summaries of screening methods, and the role insurers play in supporting their policyholders in cervical cancer prevention.
Wendy Low, Jiajia Dong
The Changing Incidence of Dementia – No Cause For Complacency
There are about 55 million people living with some form of dementia across the world, and that number is projected to rise three-fold by 2050. Some data projected a decline of new cases; however that's no cause for complacency. Insurers can be supportive by finding suitable products for the future care of patients.
Dr. Chris Ball
Diabetes Type 2 – Global Collaboration, Transformation, and Challenge
Since the discovery of insulin 102 years ago, a global epidemic of type 2 diabetes (T2DM) has evolved with an estimated 537 million adults affected worldwide. We have learned that T2DM represents a highly variable group of condition. We look at global differences, learnings, and implications for insurers.
Dr. Loraine Oman-Ganes

Find an Expert in Your Region